The AGM adopted the financial statements, including the consolidated financial statements for the financial year 1 January -
Dividend
The AGM resolved that a dividend of
Members of the Supervisory Board and their remuneration
The number of members of the Supervisory Board was confirmed to be 25.
The annual remuneration payable to the Chairman of the Supervisory Board was confirmed to be
Members of the Board of Directors and their remuneration
The number of members of the Board of Directors was confirmed to be six, and
The Chairman of the Board will be paid a monthly remuneration of
Auditor and deputy auditor
Auditing company
Board authorisation to decide on repurchase/pledge of shares
The AGM authorised the Board of Directors to decide on the acquisition of the Company's own shares by using funds included in the Company's non-restricted equity and/or accepting them as pledge on the following terms and conditions:
The shares can be acquired for the purpose of developing the company's capital structure, for use in the financing or implementing of company acquisitions and other arrangements, and for realising share-based incentive systems or otherwise to be assigned further or to be annulled.
Shares can be acquired and/or accepted as pledge in one or more lots, a maximum of 6,250,000 shares at a time; a maximum of 5,000,000 of them can be free shares and a maximum of 1,250,000 can be restricted shares.
The shares must be acquired or accepted as pledge so that the total number of shares in the company's or its subsidiary's possession or held as a pledge by them will not exceed ten (10) per cent of all the company's shares after the acquisition or accepting as pledge. The Board of Directors is entitled to acquire company's own shares in a proportion other than according to the proportions of the different types of shares and to decide on the order in which the shares are acquired.
The acquisition of the shares will be implemented on the basis of the market price formed in the public trading organised by the
As the acquisition is implemented in public trading, the shares are acquired in a proportion other than according to the proportions of the shares in the shareholders' possession. The acquisition of shares decreases the distributable non-restricted equity of the company.
The Board of Directors shall decide on other terms and conditions related to the acquisition of the company's own shares and accepting them as pledge.
The authorisation will be valid until the conclusion of the following Annual General Meeting, and until
Board authorisation to decide on the issuance of shares
The AGM authorised the Board of Directors to decide on share issues (1) by assigning a total of no more than 6,200,000 free shares that are in the company's possession and a total of no more than 1,250,000 restricted shares that are in the company's possession and (2) by giving out a total of no more than 10,000,000 new free shares.
The Board of Directors is authorised to decide to whom and in what order the company's own shares are assigned and new shares given. Shares can be assigned and given in one or more instalments.
The Board of Directors can decide on the assignment of the company's own shares and giving new shares otherwise than in a proportion where the shareholders have a primary right to the company's shares, if there exists weighty financial reason for a deviation from the company's point of view. Development of the company's capital structure, financing or implementation of company acquisitions or other arrangements and realisation of share-based incentive systems can be considered weighty financial reasons from the company's point of view.
The Board of Directors can also decide on assigning the company's own shares in public trading organised by the
The shares can also be assigned against a compensation other than money, against set-off or otherwise on certain terms and conditions.
The Board of Directors is entitled to decide on other terms and conditions of a share issue.
The authorisation will be valid until the conclusion of the following Annual General Meeting, and until
Minutes of the AGM
The minutes of the AGM will be available on the company's website (https://www.raisio.com/en/investors/corporate-governance/annual-general-meeting/) no later than on
Organizing meeting of the company's Board of Directors
At its organizing meeting held after the Annual General Meeting, the Board of Directors re-elected
The Board also decided on its committees as follows:
All members of the committees are independent of the company and its major shareholders according to the Finnish Corporate Governance Code.
Investor enquiries:
CFO
Tel. +358 400 726 808
Further information:
CLO
Tel +358 40 594 9512
At Raisio, we make food from the heart, with the aim of bringing health to ourselves and the Earth. We keep creating better plant-based and heart-healthy products so that eating healthily and within the Earth's ecological capacity can be a pleasure. Our strong brands, such as Benecol®, Härkis® and Elovena®, turn our ambitions into reality. Through our responsibility work, we make the hard choices for consumers, so that they can choose Raisio products with confidence. We have around 350 healthy food colleagues in seven countries and export to more than 40 markets around the world. Raisio's shares are listed on
https://news.cision.com/raisio-oyj/r/raisio-plc--decisions-by-the-annual-general-meeting-and-the-organizing-meeting-of-the-company-s-boar,c3958782
(c) 2024 Cision. All rights reserved., source